A. G. Herna´n et al. / Tetrahedron Letters 44 (2003) 8601–8603
8603
GlaxoSmithKline, Eli Lilly, CN Biosciences, Organon,
Pfizer and Roche.
M. Tetrahedron Lett. 2000, 41, 3377–3380; (i) Zhu, X.;
Blough, B. E.; Carroll, F. I. Tetrahedron Lett. 2000, 41,
9219–9222.
4. Bu2SnH2 was prepared by NaBH4 reduction of Bu2SnCl2
in monoglyme: Birnbaum, E. R.; Javora, P. H. J.
Organomet. Chem. 1967, 9, 379–382.
References
5. Kuivila, H. G.; Kennedy, J. D.; Tien, R. Y.; Tyminski, I.
J.; Pelczar, F. L.; Khan, O. R. J. Org. Chem. 1971, 36,
2083–2088.
1. (a) Stille, J. K. Pure Appl. Chem. 1985, 57, 1771–1780; (b)
Farina, V.; Krishnamurthy, V.; Scott, W. J. Org. React.
(New York) 1997, 50, 1–652.
6. Clark, H. C.; Furnival, S. G.; Kwon, J. T. Can. J. Chem.
2. (a) Maleczka, R. E., Jr.; Terstiege, I. J. Org. Chem. 1998,
63, 9622–9623; (b) Maleczka, R. E., Jr.; Gallagher, W. P.;
Terstiege, I. J. Am. Chem. Soc. 2000, 122, 384–385; (c)
Maleczka, R. E., Jr.; Lavis, J. M.; Clark, D. H.; Gal-
lagher, W. P. Org. Lett. 2000, 2, 3655–3658; (d) Gal-
lagher, W. P.; Terstiege, I.; Maleczka, R. E., Jr. J. Am.
Chem. Soc. 2001, 123, 3194–3204; (e) Maleczka, R. E.,
Jr.; Gallagher, W. P. Org. Lett. 2001, 3, 4173–4176.
3. See for example: (a) Gerigk, U.; Gerlach, M.; Neumann,
W. P.; Vieler, R.; Weintritt, V. Synthesis 1990, 448–452;
(b) Kuhn, H.; Neumann, W. P. Synlett 1994, 123; (c)
Dumartin, G.; Kharboutli, J.; Delmond, B.; Pereyre, M.;
Biesemans, M.; Gielen, M.; Willem, R. Organometallics
1996, 15, 19–23; (d) Chemin, A.; Deleuze, H.; Maillard,
B. Eur. Polym. J. 1998, 34, 1395–1404; (e) Nicolaou, K.
C.; Winssinger, N.; Pastor, J.; Murphy, F. Angew. Chem.,
Int. Ed. Engl. 1998, 37, 2534–2537; (f) Enholm, E. J.;
Schulte, J. P., II Org. Lett. 1999, 1, 1275–1277; (g)
Enholm, E. J.; Gallagher, M. E.; Moran, K. M.; Lom-
bardi, J. S.; Schulte, J. P., II Org. Lett. 1999, 1, 689–691;
(h) Boussaguet, P.; Delmond, B.; Dumartin, G.; Pereyre,
1963, 41, 2889–2897.
7. Resin 1: Sn: 13%=1.04 mmol/g; Cl: 3.86%=1.1 mmol/g;
13C NMR: (C6D6, 300 MHz): l 13.7, 15, 18.4, 26.0, 26.7,
27.8, 40.3 (br), 71 (br), 73.1; 119Sn NMR (C6D6; 112
MHz): l 63.8 relative to (CH3)4Sn.
Resin 2: Sn: 14.9%=1.3 mmol/g; Cl: 4.81%=1.4 mmol/g;
13C NMR (C6D6, 300 MHz): l −0.1, 16.3, 25.9, 71.1,
73.2; 119Sn NMR (C6D6; 112 MHz): l 59 relative to
(CH3)4Sn.
8. Mitchell, T. N. J. Organomet. Chem. 1973, 59, 189–197.
9. Alkynols were used as the alcohol functionality assisted
in the purification of the products, but unfunctionalised
alkynes can also be used: see Ref. 2.
10. Tin analysis was carried out by digesting the sample in
sulphuric acid followed by ICP (Inductively Coupled
Plasma) analysis, and was performed by Medac Ltd.
11. In practice the coupling and oxidative reactions of poly-
mer-supported organotin reagents has been noted in sev-
eral instances using resins with low crosslinking. For a
discussion see Ref. 3d.